OCLN and stroke disorder: Results showed there is no significant difference in the expression of ZO-1 [F (2, 6) = 0.002368; Storax vs. Model, p = 0.9944] or Occludin [F (2, 9) = 0.4009; Storax vs. Model, p = 0.4865] among the Control, Model and Storax groups at 6 h after stroke (Figures 4G,H).